tilorone has been researched along with Leukemia P388 in 1 studies
Tilorone: An antiviral agent used as its hydrochloride. It is the first recognized synthetic, low-molecular-weight compound that is an orally active interferon inducer, and is also reported to have antineoplastic and anti-inflammatory actions.
tilorone : A member of the class of fluoren-9-ones that is 9H-fluoren-9-one which is substituted by a 2-(diethylamino)ethoxy group at positions 2 and 7. It is an interferon inducer and a selective alpha7 nicotinic acetylcholine receptor (alpha7 nAChR) agonist. Its hydrochloride salt is used as an antiviral drug.
Leukemia P388: An experimental lymphocytic leukemia originally induced in DBA/2 mice by painting with methylcholanthrene.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Schulze, W | 1 |
Letsch, G | 1 |
Gutsche, W | 1 |
Wohlrabe, K | 1 |
Tresselt, D | 1 |
1 other study available for tilorone and Leukemia P388
Article | Year |
---|---|
[N-quaternary derivatives of tilorone].
Topics: Animals; Antineoplastic Agents; Chemical Phenomena; Chemistry; Fluorenes; Lethal Dose 50; Leukemia L | 1984 |